{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:48:58Z","timestamp":1710290938511},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,12]]},"DOI":"10.7759\/cureus.56031","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T15:07:20Z","timestamp":1710256040000},"source":"Crossref","is-referenced-by-count":0,"title":["Alkindi Sprinkle for Pediatric Patients With Primary Adrenocortical Insufficiency: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Alan D","family":"Kaye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munira  E","family":"Khaled","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin Nicole","family":"Bembenick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Lacey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anamika","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rucha  A","family":"Kelkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa  G","family":"Derouen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrado","family":"Ballaera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debbie","family":"Chandler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahab","family":"Ahmadzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00136-7","article-title":"Adrenal insufficiency","volume":"397","author":"Husebye ES","year":"2021","unstructured":"Husebye ES, Pearce SH, Krone NP, K\u00e4mpe O. Adrenal insufficiency. Lancet. 2021, 397:613-29. 10.1016\/S0140-6736(21)00136-7","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2021.09.011","article-title":"Secondary adrenal insufficiency: recent updates and new directions for diagnosis and management","volume":"28","author":"Gruber LM","year":"2022","unstructured":"Gruber LM, Bancos I. Secondary adrenal insufficiency: recent updates and new directions for diagnosis and management. Endocr Pract. 2022, 28:110-7. 10.1016\/j.eprac.2021.09.011","journal-title":"Endocr Pract"},{"key":"ref3","article-title":"Addison disease","author":"Munir S","year":"2024","unstructured":"Munir S, Quintanilla Rodriguez BS, Waseem M. Addison disease. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref4","article-title":"Congenital adrenal hyperplasia","author":"Momodu II","year":"2024","unstructured":"Momodu II, Lee B, Singh G. Congenital adrenal hyperplasia. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2016.04.011","article-title":"The circadian clock and human health","volume":"26","author":"Roenneberg T","year":"2016","unstructured":"Roenneberg T, Merrow M. The circadian clock and human health. Curr Biol. 2016, 26:R432-43. 10.1016\/j.cub.2016.04.011","journal-title":"Curr Biol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/17446651.2018.1455496","article-title":"Immediate-release granule formulation of hydrocortisone, Alkindi\u00ae, for treatment of paediatric adrenal insufficiency (Infacort development programme)","volume":"13","author":"Porter J","year":"2018","unstructured":"Porter J, Withe M, Ross RJ. Immediate-release granule formulation of hydrocortisone, Alkindi\u00ae, for treatment of paediatric adrenal insufficiency (Infacort development programme). Expert Rev Endocrinol Metab. 2018, 13:119-24. 10.1080\/17446651.2018.1455496","journal-title":"Expert Rev Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0248","article-title":"Quality of compounded hydrocortisone capsules used in the treatment of children","volume":"177","author":"Neumann U","year":"2017","unstructured":"Neumann U, Burau D, Spielmann S, Whitaker MJ, Ross RJ, Kloft C, Blankenstein O. Quality of compounded hydrocortisone capsules used in the treatment of children. Eur J Endocrinol. 2017, 177:239-42. 10.1530\/EJE-17-0248","journal-title":"Eur J Endocrinol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/js.2018-00380","article-title":"Hydrocortisone granules are bioequivalent when sprinkled onto food or given directly on the tongue","volume":"3","author":"Daniel E","year":"2019","unstructured":"Daniel E, Digweed D, Quirke J, Voet B, Ross RJ, Davies M. Hydrocortisone granules are bioequivalent when sprinkled onto food or given directly on the tongue. J Endocr Soc. 2019, 3:847-56. 10.1210\/js.2018-00380","journal-title":"J Endocr Soc"},{"key":"ref9","unstructured":"Alkindi Sprinkle. (2023). https.\/\/www.rxlist.com\/alkindi-sprinkle-drug.htm."},{"key":"ref10","article-title":"Hydrocortisone (Alkindi) for the treatment of adrenal insufficiency: overview","year":"2006","unstructured":"Hydrocortisone (Alkindi) for the treatment of adrenal insufficiency. overview. InformedHealth.org [Internet]. Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany; 2006."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1133376","article-title":"Adrenal crisis in infants and young children with adrenal insufficiency: management and prevention","volume":"14","author":"Bizzarri C","year":"2023","unstructured":"Bizzarri C, Capalbo D, Wasniewska MG, Baronio F, Grandone A, Cappa M. Adrenal crisis in infants and young children with adrenal insufficiency: management and prevention. Front Endocrinol (Lausanne). 2023, 14:1133376. 10.3389\/fendo.2023.1133376","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref12","article-title":"Adrenal insufficiency","author":"Alexandraki K","year":"2000","unstructured":"Alexandraki K, Sanpawithayakul K, Grossman A, et al.. Adrenal insufficiency. Endotext [Internet]. MDText.com, Inc., South Dartmouth (MA); 2000."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2022.06.005","article-title":"Diagnosis and management of adrenal insufficiency and adrenal crisis in the emergency department","volume":"63","author":"Lentz S","year":"2022","unstructured":"Lentz S, Collier KC, Willis G, Long B. Diagnosis and management of adrenal insufficiency and adrenal crisis in the emergency department. J Emerg Med. 2022, 63:212-20. 10.1016\/j.jemermed.2022.06.005","journal-title":"J Emerg Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.01.029","article-title":"Adrenal insufficiency: physiology, clinical presentation and diagnostic challenges","volume":"505","author":"Martin-Grace J","year":"2020","unstructured":"Martin-Grace J, Dineen R, Sherlock M, Thompson CJ. Adrenal insufficiency: physiology, clinical presentation and diagnostic challenges. Clin Chim Acta. 2020, 505:78-91. 10.1016\/j.cca.2020.01.029","journal-title":"Clin Chim Acta"},{"key":"ref15","article-title":"Adrenal crisis","author":"Elshimy G","year":"2024","unstructured":"Elshimy G, Chippa V, Kaur J, Jeong JM. Adrenal crisis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref16","article-title":"Adrenal insufficiency","author":"Huecker M","year":"2024","unstructured":"Huecker M, Bhutta B, Dominique E. Adrenal insufficiency. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref17","article-title":"Autoimmune polyglandular syndromes","author":"Sperling MA","year":"2000","unstructured":"Sperling MA, Angelousi A, Yau M, et al.. Autoimmune polyglandular syndromes. Endotext [Internet]. MDText.com, Inc., South Dartmouth (MA); 2000."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.17-3-258","article-title":"Adrenal insufficiency - recognition and management","volume":"17","author":"Pazderska A","year":"2017","unstructured":"Pazderska A, Pearce SH. Adrenal insufficiency - recognition and management. Clin Med (Lond). 2017, 17:258-62. 10.7861\/clinmedicine.17-3-258","journal-title":"Clin Med (Lond)"},{"key":"ref19","article-title":"Diagnosis and management of adrenal insufficiency","author":"Alexandraki K","year":"2000","unstructured":"Alexandraki K, Grossman A, Feingold KR, et al.. Diagnosis and management of adrenal insufficiency. Endotext [Internet]. MDText.com, Inc., South Dartmouth (MA); 2000."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02649-6","article-title":"Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis","volume":"71","author":"Nowotny H","year":"2021","unstructured":"Nowotny H, Ahmed SF, Bensing S, et al.. Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis. Endocrine. 2021, 71:586-94. 10.1007\/s12020-021-02649-6","journal-title":"Endocrine"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-4060","article-title":"Development and testing in healthy adults of oral hydrocortisone granules with taste masking for the treatment of neonates and infants with adrenal insufficiency","volume":"100","author":"Whitaker MJ","year":"2015","unstructured":"Whitaker MJ, Spielmann S, Digweed D, et al.. Development and testing in healthy adults of oral hydrocortisone granules with taste masking for the treatment of neonates and infants with adrenal insufficiency. J Clin Endocrinol Metab. 2015, 100:1681-8. 10.1210\/jc.2014-4060","journal-title":"J Clin Endocrinol Metab"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.17778.1","article-title":"Emerging medical therapies for congenital adrenal hyperplasia","volume":"8","author":"Speiser PW","year":"2019","unstructured":"Speiser PW. Emerging medical therapies for congenital adrenal hyperplasia. F1000Res. 2019, 8:363. 10.12688\/f1000research.17778.1","journal-title":"F1000Res"},{"key":"ref23","unstructured":"About Alkindi Sprinkle. https.\/\/www.alkindisprinkle.com\/about-alkindi-sprinkle\/."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1080\/21678707.2021.1903871","article-title":"Hydrocortisone granules in capsules for opening (Alkindi) as replacement therapy in pediatric patients with adrenal insufficiency","volume":"9","author":"Coope H","year":"2021","unstructured":"Coope H, Parviainen L, Withe M, Porter J, Ross RJ. Hydrocortisone granules in capsules for opening (Alkindi) as replacement therapy in pediatric patients with adrenal insufficiency. Expert Opinion on Orphan Drugs. 2021, 9:67-76. 10.1080\/21678707.2021.1903871","journal-title":"Expert Opinion on Orphan Drugs"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.105913","article-title":"Development and verification of an endogenous PBPK model to inform hydrocortisone replacement dosing in children and adults with cortisol deficiency","volume":"165","author":"Bonner JJ","year":"2021","unstructured":"Bonner JJ, Burt H, Johnson TN, Whitaker MJ, Porter J, Ross RJ. Development and verification of an endogenous PBPK model to inform hydrocortisone replacement dosing in children and adults with cortisol deficiency. Eur J Pharm Sci. 2021, 165:105913. 10.1016\/j.ejps.2021.105913","journal-title":"Eur J Pharm Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-020-02912-x","article-title":"A biopredictive in vitro approach for assessing compatibility of a novel pediatric hydrocortisone drug product within common pediatric dosing vehicles","volume":"37","author":"Wollmer E","year":"2020","unstructured":"Wollmer E, Karkossa F, Freerks L, et al.. A biopredictive in vitro approach for assessing compatibility of a novel pediatric hydrocortisone drug product within common pediatric dosing vehicles. Pharm Res. 2020, 37:203. 10.1007\/s11095-020-02912-x","journal-title":"Pharm Res"},{"key":"ref27","article-title":"Corticosteroids","author":"Hodgens A","year":"2024","unstructured":"Hodgens A, Sharman T. Corticosteroids. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa626","article-title":"A prospective study of children aged 0-8 years with CAH and adrenal insufficiency treated with hydrocortisone granules","volume":"106","author":"Neumann U","year":"2021","unstructured":"Neumann U, Braune K, Whitaker MJ, et al.. A prospective study of children aged 0-8 years with CAH and adrenal insufficiency treated with hydrocortisone granules. J Clin Endocrinol Metab. 2021, 106:e1433-40. 10.1210\/clinem\/dgaa626","journal-title":"J Clin Endocrinol Metab"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13447","article-title":"Absorption and tolerability of taste-masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiency","volume":"88","author":"Neumann U","year":"2018","unstructured":"Neumann U, Whitaker MJ, Wiegand S, et al.. Absorption and tolerability of taste-masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiency. Clin Endocrinol (Oxf). 2018, 88:21-9. 10.1111\/cen.13447","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13876","article-title":"Accuracy of hydrocortisone dose administration via nasogastric tube","volume":"90","author":"Daniel E","year":"2019","unstructured":"Daniel E, Whitaker MJ, Keevil B, Wales J, Ross RJ. Accuracy of hydrocortisone dose administration via nasogastric tube. Clin Endocrinol (Oxf). 2019, 90:66-73. 10.1111\/cen.13876","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjpo-2017-000198","article-title":"Content uniformity of quartered hydrocortisone tablets in comparison with mini-tablets for paediatric dosing","volume":"2","author":"Madathilethu J","year":"2018","unstructured":"Madathilethu J, Roberts M, Peak M, Blair J, Prescott R, Ford JL. Content uniformity of quartered hydrocortisone tablets in comparison with mini-tablets for paediatric dosing. BMJ Paediatr Open. 2018, 2:e000198. 10.1136\/bmjpo-2017-000198","journal-title":"BMJ Paediatr Open"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0575-8","article-title":"Predicting cortisol exposure from paediatric hydrocortisone formulation using a semi-mechanistic pharmacokinetic model established in healthy adults","volume":"57","author":"Melin J","year":"2018","unstructured":"Melin J, Parra-Guillen ZP, Hartung N, Huisinga W, Ross RJ, Whitaker MJ, Kloft C. Predicting cortisol exposure from paediatric hydrocortisone formulation using a semi-mechanistic pharmacokinetic model established in healthy adults. Clin Pharmacokinet. 2018, 57:515-27. 10.1007\/s40262-017-0575-8","journal-title":"Clin Pharmacokinet"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0969","article-title":"Primary adrenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality","volume":"176","author":"Bancos I","year":"2017","unstructured":"Bancos I, Hazeldine J, Chortis V, Hampson P, Taylor AE, Lord JM, Arlt W. Primary adrenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality. Eur J Endocrinol. 2017, 176:471-80. 10.1530\/EJE-16-0969","journal-title":"Eur J Endocrinol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/233213-alkindi-sprinkle-for-pediatric-patients-with-primary-adrenocortical-insufficiency-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T15:07:25Z","timestamp":1710256045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/233213-alkindi-sprinkle-for-pediatric-patients-with-primary-adrenocortical-insufficiency-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.56031","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,12]]}}}